Drug Type TIL therapy |
Synonyms Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection)(Grit Biotechnology), GTE-001 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Adenocarcinoma | Phase 1 | CN | 18 Jul 2024 |